Activiomics announced this week it has appointed Trevor Nicholls to its board as a non-executive chairman.
Nicholls is CEO of CABI, a non-profit intergovernmental organization owned by 46 member countries, and also serves as non-executive chairman of Oxford Nanopore Technologies. Previously, he was chief commercial officer at Affymetrix.
Denator said this week it has appointed Soren Moller to its board of directors.
Moller is managing investment director at Novo Seeds, the early-stage investment group of Novo A/S. His appointment comes in conjuction with Novo Seeds' participation in Denator's sixth funding round, which the company completed this week (See story this issue).
The University of Pennsylvania has named Benjamin Garcia a Presidential Term Professor of Biochemistry and Biophysics in Penn's Perelman School of Medicine. The Presidential Term Professorship is funded in part by a $2 million award to Penn from the Pew Charitable Trusts.
Garcia is currently an assistant professor of molecular biology at Princeton University where his research focuses on top-down proteomics, and before that he was a post-doctoral fellow at the Institute for Genomic Biology at the University of Illinois.
Michael Porter has resigned his position on the board of directors of Thermo Fisher Scientific, the company said in a recent filing with the US Securities and Exchange Commission.
Porter was first elected to the board in 2001. He was a member of the company's nominating and corporate governance and strategy and finance committees.
Agilent Technologies has appointed Solange Glaize to serve as VP and chief accounting officer, effective immediately.
Glaize has already held various posts at Agilent, including senior director of finance for the life sciences solutions unit, and VP of finance and group CFO of the Life Sciences Group. Glaize will receive an increase in her base salary to $285,000.